drugset / Trial / NCT01615627
Hypotonic Treprostinil Subcutaneous Infusion for Control of Treprostinil Related Site Pain
RandomizedCrossoverQuadruple-blindTreatment
Summary
The investigators will test whether hypotonic (diluted) remodulin solution causes less pain than the eutonic (undiluted) solution supplied by the manufacturer.
Timeline
- Start
- 2012-07-01
- Primary completion
- 2019-02-28
- Completion
- 2019-02-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Treprostinil | Other / unclassified | — | — |